Future Oncology Journal Issues Research Articles in Vol. 18, No. 33
December 24, 2022
December 24, 2022
LONDON, England, Dec. 24 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles on the following topics in its Vol. 18, No. 33 edition:
Clinical Trial Protocol:
* MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma
* Trilaciclib prior to gemcitabine plus carboplatin for metasta . . .
Clinical Trial Protocol:
* MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma
* Trilaciclib prior to gemcitabine plus carboplatin for metasta . . .